Lynn MK, Bossak BH, Sandifer PA, Watson A, Nolan MS. Contemporary autochthonous human Chagas in the USA. Acta Trop. 2020:205. https://doi.org/10.1016/j.actatropica.2020.105361.

Barry JA. Social sciences research on infectious diseases of poverty: too little and too late? PLoS Negl Trop Dis. 2014;8(6):1–6. https://doi.org/10.1371/journal.pntd.0002803. Accessed 26 Mar 2020.

WHO. World Health Organization. Chagas disease (also known as American trypanosomiasis) [Internet]. Geneva: WHO; 2020. [Revised 10/03/2020; Cited 26/03/2020] Available at https://www.who.int/en/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)

Google Scholar 

Silmoes TC, Borges LF, Parreira de Assis AC, Silva MV, dos Santos J, Meira KC. Chagas disease mortality in Brazil: a Bayesian análisis of age-period-cohort effects and forecasts for two decades. PLoS Negl Trop Dis. 2018;12(9):1–20. https://doi.org/10.1371/journal.pntd.0006798.

Article  Google Scholar 

Rassi A Jr, Rassi A, de Rezende JM. American tripanosomiasis (Chagas disease). Infect Dis Clin N Am. 2012;26:275–91. https://doi.org/10.1016/j.idc.2012.03.002.

Article  Google Scholar 

Ventura-García L, Roura M, Pell C, Posada E, Gascón J, Aldasoro E, et al. Socio-cultural aspects of Chagas disease: a systematic review of qualitative research. PLoS Negl Trop Dis. 2013;7(9):1–8. https://doi.org/10.1371/journal.pntd.0002410.

Article  Google Scholar 

Bern C. Chagas Disease. N Engl J Med. 2015;373:546–466. https://doi.org/10.1056/NEJMra1410150.

CAS  Article  Google Scholar 

Ballestero-Rodea G, Martínez-Cuevas TI, Jiménez-Ramos B, Campos AA. Chagas disease: an overview of diagnosis. J Microbiol Exp. 2018;6(3):151–7. https://doi.org/10.15406/jmen.2018.06.00207.

Article  Google Scholar 

Kawaguchi WH, Bonancio-Cerqueira L, Millan-Fachi M, Campos ML, Messias-Reason IJ, Pontarolo R. Efficacy and safety of Chagas disease drug therapy and treatment perspectives. In: Nissapatorn V, Helieh S, editors. Chagas disease – basic investigations and challenges. 1st ed. United Kingdom: IntechOpen; 2018. p. 121–52. https://doi.org/10.5772/intechopen.74845. This article provides a deep insight of the available and alternative drugs to treat Chagas disease.

Beaumier CM, Gillespie PM, Strych U, Hayward T, Hotez PJ, Bottazi ME. Status of vaccine research and development of vaccines for Chagas Disease. Vaccine. 2016;17(503):1–5. https://doi.org/10.1016/j.vaccine.2016.03.074.

Article  Google Scholar 

Freitas DS, Silva-Godinho A, Mondego-Oliveira R, de Oliveira-Cardoso F. Anti-inflammatory and antioxidant therapies for chagasic myocarditis: a systematic review. Parasitology. 2020;1:1–8. https://doi.org/10.1017/S0031182020000153.

Article  Google Scholar 

Teixeria-Holanda H, Felix-Mediano MF, Hasslocher-Moreno AM, Salles-Xavier S, Magalhaes-Saraiva R, Silvestre-Sousa A. A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial. BMC. 2018;19(507):1–3 Trial: NCT00875173.

Castilhos MP, Huguenin GVB, Rodrigues PRM, Nascimento EMD, Pereira BB, Pedrosa RC. Diet quality of patients with chronic Chagas disease in a tertiary hospital: a case-control study. Rev. Soc Bras Med Trop. 2017;60(6):795–804. https://doi.org/10.1590/0037-8682-0237-2017.

Article  Google Scholar 

Kirchoff LV, Talavera F, King JW, Chandrasekar PH. Which dietary modifications are used in the treatment of Chagas disease (American trypanosomiasis)? [Internet]. United States: WebMD; 2019. [Revised 26/04/2019; Cited 26/03/2020] Available at: https://www.medscape.com/answers/214581-112062/which-dietary-modifications-are-used-in-the-treatment-of-chagas-disease-american-trypanosomiasis. Accessed 26 Mar 2020.

Food and Drugs Administration. Benznidazole. [Internet]. United States: FDA; 2017. [Revised 26/04/2019; Cited 26/03/2020] Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209570lbl.pdf

Google Scholar 

Pan American Health Organization, World Health Organization. Guidelines for the diagnosis and treatment of Chagas disease. [Internet]. Washington: PAHO, WHO; 2019. [Revised 2019; Cited 26/03/2020] Available at: https://iris.paho.org/bitstream/handle/10665.2/49653/9789275120439_eng.pdf?sequence=6&isAllowed=y. Accessed 26 Mar 2020.

Meymandi S, Hernandez S, Park S, Sanchez D, Forsyth C. Treatment of Chagas disease in the United States. Curr Treat Options Infect Dis. 2018;10:373–88. https://doi.org/10.1007/s40506-018-0170-z. This article explains well how to treat the chronic complications of the disease and discusses the problem that has arisen since its appearance in the United States.

Medscape. Nifurtimox. [Internet]. United States: WebMD; 2019. [Revised 26/04/2019; Cited 26/03/2020] Available at: https://reference.medscape.com/drug/lampit-nifurtimox-342663#5. Accessed 26 Mar 2020.

World Health Organization. Nifurtimox. [Internet]. Geneva: WHO; 2019. [Revised 2019; Cited 26/03/2020] Available at: https://apps.who.int/medicinedocs/es/d/Jh2924s/2.11.2.html. Accessed 26 Mar 2020.

Benatti RD, Oliveria H, Bacal F. Heart transplantation for Chagas cardiomyopathy. J Heart Lung Transpl. 2017;36(6):597–603. https://doi.org/10.1016/j.healun.2017.02.006.

Article  Google Scholar 

Pinazo MJ, Cañas E, Elizalde JI, García M, Gascón J, Gimeno F, et al. Diagnosis, management and treatment of chronic Chagas gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic. Gastroenterol Hepatol. 2010;33(3):191–200. https://doi.org/10.1016/j.gastrohep.2009.07.009.

Article  PubMed  Google Scholar 

Cheng A, Slaughter MS. Heart transplantation. J Thorac Dis. 2014;6(8):1105–9. https://doi.org/10.3978/j.issn.2072-1439.2014.07.37.

Article  PubMed  PubMed Central  Google Scholar 

Deng MC. Cardiac transplantation. Heart. 2002;87:177–84.

Article  Google Scholar 

Benatti RD, Oliveira GH, Bacal F. Heart transplantation for Chagas cardiomyopathy. J Heart Transplantation for Chagas Cardiomyopathy. J Heart Lung Transplant. 2017;36(6):597–603. https://doi.org/10.1016/j.healun.2017.02.006.

Article  Google Scholar 

Kilic A, Phillips G, Chimanji N, Hasan A, Higgins RSD, Whitson BA, et al. Cost comparison between heart transplantation and left ventricular assist device implantation. J Cardiac Fail. 2014;20(8):212. https://doi.org/10.1016/j.cardfail.2014.06.238.

Article  Google Scholar 

Oddsdottir M. Laparoscopic cardiomyotomy. In: Scott-Conner CE, editor. The SAGES Manual. New Yor, NY: Springer. https://doi.org/10.1007/0-387-30485-1_24.

Lopes LR, Silva-Braga N, Carvalho de Oliveira G, Coelho-Neto JS, Camargo MA, Andreollo NA. Results of the surgical treatment of non-advanced megaesophagus using Heller-Pinotti’s surgery: laparotomy vs laparoscopy. Clinics (Sao Paulo). 211(66 (1)):41–6.

Martínez-Regueira FM, Rotellar F, Baixaull J, Valenti V, Gil A, Hernández-Lizoain JL. Estado actual de la cirugía laparoscópica esofágica. Anales Sis San Navarra. 2005;28(3):11–9.

Google Scholar 

Miller HJ, Neupane R, Fayezizadeh M, Majumder A, Marks JM. POEM is a cost-effective procedure: cost-utility analysis of endoscopic and surgical treatment options in the management of achalasia. Surg Endosc. 2017;31(4):1636–42. https://doi.org/10.1007/s00464-016-5151-z.

Article  PubMed  Google Scholar 

Santos-García RL, de Matos BM, Féres O, Ribeiro da Rocha JJ. Surgical treatment of Chagas megacolon. Critical analysis of outcome in operative methods. Acta Cir Bras. 2008;23(1):83–92. https://doi.org/10.1590/S0102-86502008000700015.

Article  Google Scholar 

Fretes-Zárate R, Medina-Gutiérrez J, Muñoz-Rodas D. Chagasic megacolon in Paraguay: surgical aspects and futures perspectives. Mem Inst Investig Cienc Salud. 2013;11(2):97–104.

Google Scholar 

Pereira MC, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverría LE, et al. Chagas cardiomyopathy: an update of current clinical knowledge and management. Circulation. 2018;138:169–209. https://doi.org/10.1161/CIR.0000000000000599.

Article  Google Scholar 

Vinicius-Simoes M, Moreira-Dias-Romano M, Schmidt A, Suely-Macedo-Martins K, Martín-Neto JA. Chagas disease cardiomyopathy. Int J Cardiovasc Sci. 2018;31(2):173–89. https://doi.org/10.5935/2359-4802.20180011.

Article  Google Scholar 

Rodrigues JLF, Mendes FSNS, Pinto VLM, da Silva PS, Sperandio da Silva GM, Pinheiro RO, et al. A cardiac rehabilitation exercise program potentially inhibits progressive inflammation in patients with severe Chagas cardiomyopathy: a pilot single-arm clinical trial. J Res Med Sci. 2020;25:18. https://doi.org/10.4103/jrms.JRMS_175_18.

Article  Google Scholar 

De Souza-Nogueira-Sardinha-Mendez F, Silvestre-Sousa A, de Castro-César-Souza FC, Mattos-Pinto VL, Simplicio-Silva P, Malgalhaes-Saraiva R, et al. Effect of physical exercise training in patients with Chagas heart disease: study protocol for a randomized controlled trial (PEACH study). BMC. 2016;17:433. https://doi.org/10.1186/s13063-016-1553-4.

Article  Google Scholar 

Sales Junior P, Molina I, Fonseca Murta S, Sánchez-Montalvá A, Salvador F, Corrêa-Oliveira R, et al. Experimental and clinical treatment of Chagas disease: a review. Am J Trop Med Hyg. 2017;97(5):1289–303. https://doi.org/10.4269/ajtmh.16-0761. This article has detailed information about the clinical trails in which the approved and experimental drugs to treat the disease have been tested.

National Center for Advancing Translational Sciences. Albaconazole. [Internet]. United States: NIH; 2019. [Revised 2019; Cited 06/04/2020] Available at: https://drugs.ncats.io/drug/YDW24Y8IAB. Accessed 26 Mar 2020.

PMJA G, Urbina M, LCC L, Afonso VM, GL VWLT, et al. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts. Antimicrob Agents Chemother. 2004;48:4286–92. https://doi.org/10.1128/AAC.01742-09.

CAS  Article  Google Scholar 

Guedes P, Silva G, Gutierrez F, Silva J. Current status of Chagas disease chemotherapy. Exp Rev. Anti-infect Ther. 2011;9(5):609–20. https://doi.org/10.1586/eri.11.31.

Article  Google Scholar 

National Center for Advancing Translational Sciences. Itraconazole. [Internet]. United States: NIH; 2019. [Revised 2019; Cited 06/04/2020] Available at: https://drugs.ncats.io/drug/304NUG5GF4. Accessed 26 Mar 2020.

Apt W, Arribada A, Zulantay I, Rodríguez J, Saavedra M, Muñoz A. Treatment of CD with itraconazole: electrocardiographic and parasitological conditions after 20 years of follow-up. J Antimicrob Chemother. 2013;68:2164–9. https://doi.org/10.1093/jac/dkt135.

CAS  Article  PubMed  Google Scholar 

World Health Organization. Itraconazole. [Internet]. Geneva: WHO; 1999. [Revised 2019; Cited 06/04/2020] Available at: https://apps.who.int/medicinedocs/es/d/Jh2920s/24.8.html. Accessed 26 Mar 2020.

Bethesda. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. [Internet]. United States: Institute of Diabetes and Digestive and Kidney Diseases; 2012. [Revised 17/05/2017; Cited 06/04/2020] Available at: https://www.ncbi.nlm.nih.gov/books/NBK548273/. Accessed 26 Mar 2020.

National Center for Advancing Translational Sciences. Posaconazole. [Internet]. United States: NIH; 2019. [Revised 2019; Cited 06/04/2020] Available at: https://drugs.ncats.io/drug/6TK1G07BHZ. Accessed 26 Mar 2020.

Molina I, Gómez i Prat J, Salvador F, Treviño B, Sulleiro E, Serre N, et al. Randomized trial of posaconazole and benznidazole for chronic Chagas’ disease. NEJM. 2014;370:1899–908.

Article  Google Scholar 

Morillo CA, Waskin H, Sosa-Estani S, del Carmen Bangher M, Cuneo C, Milesi R, et al. Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers. J Am Col Cardiol. 2017;69(8):939–47. https://doi.org/10.1016/j.jacc.2016.12.023.

CAS  Article  Google Scholar 

Food and Drugs Administration. Posaconazole. [Internet]. United States: FDA; 2015. [Revised 11/2015; Cited 06/04/2020] Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022003s018s020,0205053s002s004,0205596s001s003lbl.pdf. Accessed 26 Mar 2020.

National Center for Advancing Translational Sciences. Ravuconazole. [Internet]. United States: NIH; 2019. [Revised 2019; Cited 06/04/2020] Available at: https://drugs.ncats.io/substance/95YH599JWV. Accessed 26 Mar 2020.

National Library of Medicine. Proof-of-concept study of E1224 to treat adult patients with Chagas disease. [Internet]. United States: NIH; 2011. [Revised 21/122011; Cited 06/04/2020] Available at: https://clinicaltrials.gov/ct2/show/record/NCT01489228. Accessed 26 Mar 2020.

Torrico F, Gascon J, Ortiz L, Alonso-Vega C, Pinazo MJ, et al. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomized, placebo-controlled trial. Lancet Infect Dis. 2018;18(4):419–30. https://doi.org/10.1016/S1473-3099(17)30538-8.

CAS  Article  PubMed  Google Scholar 

National Center for Advancing Translational Sciences. Voriconazole. [Internet]. United States: NIH; 2019. [Revised 2019; Cited 06/04/2020] Available at: https://drugs.ncats.io/drug/JFU09I87TR. Accessed 26 Mar 2020.

Urbina J, Payares G, Sanoja C, Lira R, Romanha A. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease. Int J Antimicrobi Agents. 2003;21(1):27–38. https://doi.org/10.1016/s0924-8579(02)00273-x.

CAS  Article  Google Scholar 

Gulin J, Eagleson M, Postan M, Cutrullis R, Freilij H, Bournissen F, et al. Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection. J Antimicrob Chemo. 2012;68(4):888–94. https://doi.org/10.1093/jac/dks478.

CAS  Article  Google Scholar 

US Department of Health and Human Services. Voriconazole. [Internet]. United States: AIDS info; 2019. [Revised 2019; Cited 06/04/2020] Available at: https://aidsinfo.nih.gov/drugs/475/voriconazole/113/professional. Accessed 26 Mar 2020.

Corrales M, Cardozo R, Segura MA, Urbina JA, Basombrío MA. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas’ disease. Antimicrob Agents Chemother. 200;49(4):1556–60 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1068647/. Accessed 26 Mar 2020.

Urbina JA, Payares G, Sanoja C, Molina J, Lira R, Brener Z, et al. Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains. Int J Antimicrob Agent. 2003;21(1):39–48. https://doi.org/10.1016/S0924-8579(02)00274-1.

CAS  Article  Google Scholar 

National Center for Advancing Translational Sciences. Amiodarone. [Internet]. United States: NIH; 2019. [Revised 2019; Cited 06/04/2020] Available at: https://drugs.ncats.io/drug/N3RQ532IUT. Accessed 26 Mar 2020.

Benaim G, Paniz Mondolfi A. The emerging role of amiodarone and dronedarone in Chagas disease. Nature Rev. Cardiol. 2012;9(10):605–9. https://doi.org/10.1038/nrcardio.2012.108.

CAS  Article  Google Scholar 

Food and Drugs Administration. Amiodarone. [Internet]. United States: FDA; 1998. [Revised 10/2018; Cited 06/04/2020] Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf. Accessed 26 Mar 2020.

National Library of Medicine. Selenium Treatment and Chagasic Cardiopathy (STCC) (STCC). [Internet]. United States: NIH; 2009. [Revised 10/11/2011; Cited 06/04/2020] Available at: https://clinicaltrials.gov/ct2/show/NCT00875173?cond=selenium+chagas&draw=2&rank=1. Accessed 26 Mar 2020.

Cunha JP. Selenium. [Internet]. United States: RxList; 2016. [Revised 2019; Cited 06/04/2020] Available at: https://www.rxlist.com/consumer_selenium_selepen/drugs-condition.htm. Accessed 26 Mar 2020.

Bahia MT, de Andrade IM, Martins TA, do Nascimento ÁF, Diniz L de F, Caldas IS, et al. Fexinidazole: a potential new drug candidate for CD. PLoS Negl Trop Dis. 2012;e1870:6.

Bahia MT, et al. Antitrypanosomal activity of fexinidazole metabolites, potential new drug candidates for CD. Antimicrob Agents Chemother. 2014;58:4362–70.

Article  Google Scholar 

Drugs for Neglected Diseases. Fexinidazole for Chagas. [Internet]. United States: NIH; 2015. [Revised 15/07/2015; Cited 06/04/2020] Available at: https://www.dndi.org/diseases-projects/portfolio/fexinidazole-chagas/. Accessed 26 Mar 2020.

WHO interim guidelines for the treatment of gambiense human African trypanosomiasis. Geneva: World Health Organization; 2019, Fexinidazole. Available from: https://www.ncbi.nlm.nih.gov/books/